PortfoliosLab logo

ProShares UltraShort Nasdaq Biotechnology (BIS)

ETF · Currency in USD · Last updated Mar 24, 2023

BIS is a passive ETF by ProShares tracking the investment results of the NASDAQ Biotechnology Index (-200%). BIS launched on Apr 7, 2010 and has a 0.95% expense ratio.

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in ProShares UltraShort Nasdaq Biotechnology in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $46 for a total return of roughly -99.54%. All prices are adjusted for splits and dividends.

BIS (ProShares UltraShort Nasdaq Biotechnology)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BIS


ProShares UltraShort Nasdaq Biotechnology had a return of 10.79% year-to-date (YTD) and -8.69% in the last 12 months. Over the past 10 years, ProShares UltraShort Nasdaq Biotechnology had an annualized return of -31.83%, while the S&P 500 had an annualized return of 9.64%, indicating that ProShares UltraShort Nasdaq Biotechnology did not perform as well as the benchmark.

1 month12.98%-3.20%
6 months-14.43%4.19%
1 year-8.69%-12.48%
5 years (annualized)-23.97%8.83%
10 years (annualized)-31.83%9.64%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ProShares UltraShort Nasdaq Biotechnology Sharpe ratio is -0.16. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

BIS (ProShares UltraShort Nasdaq Biotechnology)
Benchmark (^GSPC)

Dividend History

ProShares UltraShort Nasdaq Biotechnology granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to $0.00 per share.


Dividend yield


Monthly Dividends

The table displays the monthly dividend distributions for ProShares UltraShort Nasdaq Biotechnology. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

BIS (ProShares UltraShort Nasdaq Biotechnology)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the ProShares UltraShort Nasdaq Biotechnology. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ProShares UltraShort Nasdaq Biotechnology is 99.76%, recorded on Sep 2, 2021. The portfolio has not recovered from it yet.



To Bottom


To Recover



-99.76%Jul 7, 20102717Sep 2, 2021
-13.04%Jun 10, 20103Jun 15, 20109Jul 1, 201012
-11.83%May 7, 20104May 12, 20105May 20, 20109
-9.45%May 27, 20104Jun 3, 20102Jun 8, 20106
-6.59%Apr 28, 20102Apr 29, 20104May 5, 20106
-2.89%Apr 9, 20105Apr 15, 20104Apr 21, 20109
-1.87%Apr 23, 20101Apr 23, 20102Apr 27, 20103
-1.43%Jul 2, 20101Jul 2, 20101Jul 6, 20102

Volatility Chart

Current ProShares UltraShort Nasdaq Biotechnology volatility is 46.16%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

BIS (ProShares UltraShort Nasdaq Biotechnology)
Benchmark (^GSPC)